MMJ Recs

JANUARY 25, 2022

So now that medical marijuana is finally available in Ohio, how do you get an Ohio MMJ card in 2022? Not all doctors in Ohio are certified to recommend medical marijuana treatment. How Do I Get My Ohio MMJ Card In 2022? What Are The Qualifying Conditions For A Medical Card In Ohio In 2022? Read on to find out!

Dispensary 52

Dispensary Chronic Pain Programs Treatment 52

MMJ Recs

FEBRUARY 4, 2022

If you’ve decided that this is the year you want to start using MMJ to alleviate your symptoms, read on for more information on how to get your Oklahoma MMJ card in 2022. Residents of the state of Oklahoma qualify for an OK MMJ card provided that they have a medical condition that a licensed state physician deems suitable for MMJ treatment.

Conditions 52

Conditions Treatment Edibles Patients 52

Project CBD

APRIL 26, 2023

He had never taken anti-psychotic drugs nor received psychological treatment. Due to its excellent tolerability and promising efficacy … and its innovative new mechanisms of action, we decided to offer a respective treatment with cannabidiol to [the] patient,” they write. Cannabidiol as a potential treatment for psychosis.”

CBD 289

CBD Treatment Cannabinoids Medicine 289

TheAnswerPage

FEBRUARY 26, 2022

Have any states legalized the use of cannabis for medicinal purposes since the start of 2022? states in legalizing marijuana for medical use in February, 2022. Yes, Mississippi joined 36 other U.S.

Treatment 52

Treatment Legislation Conditions Medicine 52

Cannabis Law Report

AUGUST 13, 2021

Derived from Salvia divinorum, SalA is a unique non-nitrogenous agonist of the kappa-opioid receptor (KOR) with potential use in treatment-resistant depression (TRD), substance use disorder (SUD) and pain. Clinically, there are published reports of the potential benefits of Salvia divinorum in the treatment of TRD. BERLIN, Aug.

Conditions 105

Conditions Research and Development Clinical Trials Treatment 105

CannaMD

MAY 21, 2022

Finding the best treatment for autism has been a lifelong journey for many parents and caretakers. There is currently no known cure for autism, but with medical cannabis, there is hope for safe and effective treatment for autism symptoms.

Treatment 85

Treatment Cannabis Conditions 85

Project CBD

JUNE 7, 2023

Recent papers explore the potential role of BCP in treating a wide range of conditions including non-alcoholic fatty liver disease, chronic pain, and substance abuse. Medical scientists are studying beta-caryophyllene as a treatment for non-alcoholic fatty liver disease, chronic pain, and substance abuse. 48,4 (2022): 857-882.

Terpenes 227

Terpenes Chronic Pain Cannabinoids Food 227

TheAnswerPage

AUGUST 27, 2022

“The Answer of the Day” series on the treatment effects of cannabinoids continues… According to randomized controlled trials, which health conditions does dronabinol (Marinol – a synthetic THC product) effectively treat? BMC Med 20, 259 (2022). Spanagel, R. See the Answer.

Chronic Pain 52

Chronic Pain Cannabinoids Treatment THC 52

TheAnswerPage

AUGUST 28, 2022

“The Answer of the Day” series on the treatment effects of cannabinoids continues… According to randomized controlled trials, which health conditions does nabiximols (Sativex – ~50:50 THC:CBD plant-derived product) effectively treat? BMC Med 20, 259 (2022). Spanagel, R. See the Answer.

Chronic Pain 52

Chronic Pain Therapy Sleep Cannabinoids 52

Cannabis Law Report

OCTOBER 1, 2021

TD-0148A is currently in preclinical pharmacology and other IND-enabling studies and in 2022, BetterLife will file its IND and start Phases 1 and 2 in healthy subjects for major depressive disorder. BetterLife is already in advanced stages of GMP manufacturing TD-0148A and initiated the necessary preclinical IND-enabling studies for TD-0148A.

Treatment 52

Treatment Conditions Media 52

Leafwell

JANUARY 11, 2022

Anxiety is a common mental health condition that is on the rise. Only about 37 percent of people afflicted with anxiety receive treatment. According to the Anxiety and Depression Association of America (ADAA), 40 million U.S. adults grapple with anxiety disorders each year. The 63 percent of anxiety-plagued.

CBD 63

CBD Treatment Conditions Cannabis 63

Cannabis Law Report

JULY 13, 2022

Here’s what they posted 12 July 2022. Import, Advertising and Supply Compliance Priorities 2022-23. 12 July 2022. Import, Advertising and Supply Compliance Priorities 2022-23. Compliance Priority. Deter and address the unlawful import, advertising and supply of unapproved therapeutic goods associated with COVID-19.

Compliance 52

Compliance Compliance Wellness and Beauty Vaping 52

Cannabis Law Report

SEPTEMBER 29, 2022

Australia’s drugs regulator issues 73 infringement notices over claims prescriptions could treat conditions such as cancer and epilepsy. 27 September 2022. It is also alleged that the unlawful advertising included unapproved references to the treatment of serious diseases or conditions, including in some cases cancer and epilepsy.

Epilepsy 52

Epilepsy Conditions Media Medicine 52

Veriheal

JANUARY 26, 2023

Bipolar disorder is a complex condition that impacts millions worldwide, leading to extreme mood swings, intense emotional episodes, and difficulty managing day-to-day life. Further exploration of this possibility is underway to provide better care and more effective therapies for individuals living with the condition.

Treatment 98

Treatment Cannabinoids Conditions Pharmaceutical 98

Veriheal

MARCH 20, 2023

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Smith cited results from clinical trials showing that MDMA holds promise in the treatment of PTSD. Connecticut Gov. Minnesota Rep. Missouri Rep.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

TheAnswerPage

JUNE 29, 2022

However, purified CBDV is currently being evaluated for other conditions, including as a treatment for behavioral symptoms in patients with Prader Willi Syndrome (10 mg/kg/day, NCT03848481) and in autism (NCT03202303 and NCT03849456). That trial did not continue. Schlag, A.K., O’Sullivan, S.E,

Clinical Trials 59

Clinical Trials Epilepsy Pharmaceutical Treatment 59

TheAnswerPage

JUNE 21, 2022

There is a high strength of evidence for the efficacy of cannabinoid-based medicines for the treatment of intractable epilepsy, multiple sclerosis and cancer-related nausea. Which of these 3 conditions has the greatest relative number of patients using cannabinoid -based medicines to treat the condition?

Epilepsy 52

Epilepsy Cannabinoids Medicine Conditions 52

Illinois News Joint

APRIL 27, 2024

Suzanne Mulvehill is a Clinical Sexologist, Orgasmologist, and the Executive Director of the Female Orgasm Research Institute , which is dedicated to conducting research and identifying scientifically based treatments to reduce the persistently high percentage of women suffering from orgasm difficulty and its co-morbid conditions.

Research and Development 85

Research and Development Events Environment Education 85

Cannabis Law Report

DECEMBER 21, 2021

This UK-based company caught our attention in 2021 for its team of renowned psychedelic researchers, including chief research officer Professor David Nutt, chief medical officer Dr. Ben Sessa, and head of ketamine psychotherapy Dr. Celia Morgan, as well as its unique studies into ketamine treatment for addiction and gambling addiction.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

TheAnswerPage

JANUARY 9, 2022

However, purified CBDV is currently being evaluated for other conditions, including as a treatment for behavioral symptoms in patients with Prader Willi Syndrome (10 mg/kg/day, NCT03848481) and in autism (NCT03202303 and NCT03849456). That trial did not continue. Schlag, A.K., O’Sullivan, S.E,

Clinical Trials 59

Clinical Trials Epilepsy Pharmaceutical Treatment 59

TheAnswerPage

MAY 20, 2022

Has any national drug administration approved a CBD-containing product for therapeutic use in conditions other than epilepsy? Regulatory approval has been obtained in numerous countries outside the United States for the treatment of multiple sclerosis symptoms (nerve pain, spasticity, overactive bladder, and other symptoms).

Nerve Pain 52

Nerve Pain Epilepsy Pharmaceutical Cannabinoids 52

TheAnswerPage

DECEMBER 31, 2021

There is a high strength of evidence for the efficacy of cannabinoid-based medicines for the treatment of intractable epilepsy, multiple sclerosis and cancer-related nausea. Which of these 3 conditions has the greatest relative number of patients using cannabinoid -based medicines to treat the condition?

Epilepsy 52

Epilepsy Cannabinoids Medicine Conditions 52

SpeedWeed

AUGUST 4, 2021

If lawmakers ultimately decide not to pass the proposed legislation, the Coalition to Regulate Marijuana Like Alcohol can collect an additional 130,000 signatures to place its proposed law before voters on the November 2022 ballot. 3% for a Division of Cannabis Control, which would oversee the adult-use cannabis industry.

Conditions 52

Conditions Dispensary Cultivation Education 52

TheAnswerPage

MAY 16, 2022

A seizure disorder is a qualifying condition in many medical marijuana state programs. The effect of epidiolex (cannabidiol) on serum levels of concomitant anti-epileptic drugs in children and young adults with treatment-resistant epilepsy in an expanded access program. Friedman D, Cilio MR, Tilton N, et al. See the Answer.

Epilepsy 52

Epilepsy Programs Treatment CBD 52

Illinois News Joint

FEBRUARY 8, 2023

With a philosophy rooted in trauma-informed care, they believe in client-led healing and strive to truly listen and collaborate with patients to create individualized treatment plans that meet unique needs and lifestyles. We work with patients of all ages with a wide variety of conditions.

Patients 84

Patients Treatment Environment Conditions 84

The Cannigma

JULY 12, 2022

Roll out of the program has been slow, and as of June 2022, there were still no doctors certified to issue prescriptions, no licensed dispensaries, and no legal farming of cannabis products. Unlike other states, Alabama requires doctors to document a failure of conventional medical treatment before issuing a medical cannabis prescription.

Legalization 122

Legalization Chronic Pain Programs Treatment 122

TheAnswerPage

JANUARY 10, 2022

A thorough 2021 review article summarized the current research evaluating the relationship between cannabinoid-based medicines and the treatment of IBD. Also, some cannabinoids increase appetite. A summary of their highlights include the following: “Patients with IBD often experience pain, nausea, and decreased appetite. Kumar, A. &

Patients 59

Patients Cannabinoids Treatment Conditions 59

Cannabis Law Report

SEPTEMBER 7, 2022

Since the legalisation of medical cannabis in the UK in 2018, there is little education surrounding medical cannabis and how it can help a large variety of conditions, should traditional medicine leave patients with an ‘unmet clinical need.’ . Cantourage Clinic is a leading medical cannabis clinic in the UK with a difference. .

Patients 52

Patients Conditions Treatment Education 52

Veriheal

JANUARY 24, 2023

With its abundance of medicinal properties and non-addictive nature, why does marijuana remain an untapped resource for researchers wanting to find treatments for debilitating chronic diseases like Parkinson’s? Do not attempt to self-diagnose or prescribe treatment based on the information provided. So what gives?

DEA 98

DEA Treatment Medicine Pets 98

TheAnswerPage

JULY 20, 2022

Today’s Answer of the Day is the first of a series of questions and answers focusing on the use of cannabinoid-based medications for the treatment of chronic pain. “The multifaceted analgesic and anti-inflammatory properties of cannabinoids may positively influence the perception of pain across different conditions.”

Chronic Pain 52

Chronic Pain Cannabinoids THC Treatment 52

MMJ Recs

JANUARY 20, 2024

Let’s take a closer look at medical marijuana laws in Maryland and how they affect those in need of MMJ treatment! The state’s thoughtful approach seeks to ensure that those with genuine medical needs have access to this alternative treatment while maintaining a balance between patient care and preventing misuse.

Law 52

Law Marijuana Patients Chronic Pain 52

The Cannigma

JULY 5, 2022

The program was legalized in 2015 and patients with qualifying conditions can get a prescription for up to 20oz of low THC oil, capsules, patches, or lotion. But it is a medical program in name only, because as of June 2022 there were no licensed dispensaries in Georgia. In 2015, Georgia legalized possession of up 20 fl.

Law 96

Law Decriminalization Programs Patients 96

Cannabis Law Report

APRIL 14, 2022

Local governments may also impose zoning conditions on cannabis facilities, including but not limited to buffer zones, density conditions, hours of operation, odor control requirements, necessary operating permits, and storefront characteristics.

Environment 52

Environment Agriculture Compliance Compliance 52

Veriheal

MARCH 23, 2024

However, the Russian invasion in 2022 changed the conversation dramatically. Medical professionals have suggested that cannabis could be a valuable tool in treating these conditions. This European trend shows a growing acceptance of cannabis as a medical treatment.

Legalization 109

Legalization Chronic Pain Sleep Policy 109

The Cannigma

JUNE 25, 2022

Poland established a medical cannabis program in 2017, which allows for a range of cannabis products to be prescribed for a range of medical conditions. Qualifying conditions include chronic pain, multiple sclerosis, spasticity, chemo-induced nausea, and treatment-resistant epilepsy. Poland and cannabis.

Legalization 108

Legalization Supply Chain Chronic Pain Tincture 108

Cannabis Law Report

JANUARY 24, 2022

DUBLIN–(BUSINESS WIRE)–The “North America Legal Cannabis Market Size, Share & Trends Analysis Report by Sources (Marijuana, Hemp), by Derivatives (CBD, THC), by End Use (Medical, Recreational), and Segment Forecasts, 2022-2028” report has been added to ResearchAndMarkets.com’s offering. from 2022 to 2028.

Legalization 52

Legalization Supply Chain Chronic Pain Recreational 52

Cannabis Law Report

APRIL 21, 2022

Apr 20, 2022. NEW ORLEANS , April 20, 2022 /PRNewswire/ — Gary Hess , the founder and CEO of the Veterans Alliance for Holistic Alternatives (VAHA), announced today that four groundbreaking physicians are joining the VAHA Medical Advisory Board. “The patient is our textbook. ” Hess said. Full Bios Attached here ).

Therapy 52

Therapy Education Treatment Patients 52